← Home / CO-DIAGNOSTICS, INC. (CODX)
Stock Analysis
CO-DIAGNOSTICS, INC. (CODX)
CODX
CODX · Market data
1.44 -7.69%
Track CODX in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when CODX price is:
52W Range Position
0%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-02 19:57 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
Fundamentals
Moderate / Negative
Price Structure
Vulnerable
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
Break Above
Confirmation improves above resistance.
2.82
🎯
Next Objective
Pattern-derived target if setup continues.
×
Thesis Break
Scenario weakens below invalidation.
Below —
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
31
Equity Offering / Capital Raise
MEDIUM
CODX equity financing update
On July 30, 2026, Co-Diagnostics, Inc.
8-K Filing SEC EDGAR
JUL
27
Equity Offering / Capital Raise
HIGH
CODX equity financing update
On July 27, 2026, the Company and Maxim entered into an amendment to the Original Equity Distribution Agreement (the “Equity Distribution Agreement Amendment”), which, among other things, removed the fixed aggregate dollar limitation on sales under the Original Equity Distribution Agreement, such that future offers...
8-K Filing SEC EDGAR
MAY
21
Material Agreement
MEDIUM
CODX material agreement
On May 19, 2026, Co-Diagnostics, Inc.
8-K Filing SEC EDGAR
What's Driving CODX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 2.82 for confirmation and for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
28.1
Price Chart
CODX — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$5.2M
Company size
EV
$773,710
Debt-adjusted value
P/E
-0.1
Not meaningful
P/S
7.2
Balanced
P/B
0.3
Low book multiple
EV/Sales
1.1
Low sales multiple
EV/EBIT
-0.0
Not meaningful
P/FCF
-0.2
Not meaningful
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
Revenue Growth
Moderate
Profitability
Negative
Cash Flow
Recovering
Balance Sheet
Strong
💵 Revenue
145,954
≈ Moderate
📈 Net Income
-9.14M
↘ Negative
🧮 EPS (Basic)
-4.06
↘ Negative
CO-DIAGNOSTICS, INC.